Cerebrovascular accident associated with dipyridamole thallium-201 myocardial imaging: case report. 1993

J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
Department of Radiology, University of Utah School of Medicine, Salt Lake City.

A patient with known aortoiliac occlusive disease and hypertension suffered a cerebrovascular accident 6.5 min after the administration of intravenous dipyridamole during a 201Tl myocardial study. Despite aminophylline administration, the patient developed a completed stroke. The mechanism most likely responsible for precipitating this patient's stroke is dipyridamole-induced vascular steal. Although dipyridamole-201Tl myocardial imaging is relatively free of major complications, the morbidity and mortality associated with a cerebrovascular accident is significant. The possibility of precipitating a cerebrovascular accident during dipyridamole-201Tl imaging should be considered in all patients with significant risk factors for stroke before performing a dipyridamole cardiac study.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013793 Thallium A heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl. Thallium-205,Thallium 205

Related Publications

J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
April 1995, The Annals of pharmacotherapy,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
April 1986, British heart journal,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
September 1989, DICP : the annals of pharmacotherapy,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
December 1989, Angiology,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
November 1988, Clinical nuclear medicine,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
April 2003, Nihon rinsho. Japanese journal of clinical medicine,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
August 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
February 1981, Zeitschrift fur Kardiologie,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
October 1986, Nederlands tijdschrift voor geneeskunde,
J H Whiting, and F L Datz, and F V Gabor, and S R Jones, and K A Morton
January 1992, Pharmacotherapy,
Copied contents to your clipboard!